Tumor-infiltrating DCs suppress nucleic acid–mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1

Chiba, Shigeki, Baghdadi, Muhammad, Akiba, Hisaya, Yoshiyama, Hironori, Kinoshita, Ichiro, Dosaka-Akita, Hirotoshi, Fujioka, Yoichiro, Ohba, Yusuke, Gorman, Jacob V, Colgan, John D, Hirashima, Mitsuomi, Uede, Toshimitsu, Takaoka, Akinori, Yagita, Hideo, Jinushi, Masahisa·2012·Nature Immunology
DOI 10.1038/ni.2376

Cited by (838)

Items 701–800 of 838

  1. Context-dependent release of HMGB1: cell death mode, cell type and LPS stress drive monomer and heterocomplex formation
    Harini Pechiappan, Rebecka Heinbäck, Sigrid Stråtveit Gravning, Kjerstin Jakobsen, Richard Davies, Cecilia Aulin, Helena Erlandsson Harris · 2026 · Molecular Medicine
  2. The Signaling Networks of TIM-3, TGF-β, and STING in Glioblastoma
    Farah Ahmady, Blaine M. H. Carnie, Grace E. C. Anderson, Emerson Achari, Amit Sharma, Adrian A. Achuthan, George Kannourakis, Rodney Brian Luwor · 2026 · Cells
  3. Therapeutic potential of trained immunity for malignant disease
    Hiroyuki Takahashi, Daibo Kojima, Masato Watanabe · 2024 · Immunological Medicine
  4. Immune checkpoints in B-cell Lymphoma: Still an Unmet challenge from Basic research to clinical practice
    Sijia Li, Yuanyuan Pan, Ruyu Ye, Yu Wang, Li Li · 2024 · International Immunopharmacology
  5. Immune checkpoints and ncRNAs: pioneering immunotherapy approaches for hematological malignancies
    Samira Anvari, Mohsen Nikbakht, Mohammad Vaezi, Sedigheh Amini‐Kafiabad, Mohammad Ahmadvand · 2024 · Cancer Cell International
  6. The Immune Contexture and Cancer Therapy Aspects of the TIM-3 Checkpoint Pathway
    Yunxuan Xie · 2021 · E3S Web of Conferences
  7. Perspective Chapter: Dendritic Cells in the Tumor Microenvironment
    Dan Jin, Laura Falceto Font, Catherine T. Flores · 2023 · IntechOpen eBooks
  8. Exploring shared targets in cancer immunotherapy and cancer-induced bone pain: Insights from preclinical studies
    Ruofan Zhang, Yachen Yang, Xiang Li, Chunmeng Jiao, Mengping Lou, Wen‐Li Mi, Qi‐Liang Mao‐Ying, Yu‐Xia Chu, Yan-Qing Wang · 2024 · Cancer Letters
  9. Immunology and Immunotherapy of Breast Cancer
    John Stagg, Sherene Loi · 2015 · Springer eBooks
  10. miRNA Regulation of Programmed Cell Death-1 in T Cells: Potential Prognostic and Therapeutic Markers in Melanoma
    Nathan Johnston · 2014 · Scholarship@Western (Western University)
  11. Aspects immunologiques du cancer de l’ovaire : perspectives thérapeutiques
    M. Nayama, Pierre Collinet, Michel Salzet, D. Vinatier · 2016 · Journal de gynécologie, obstétrique et biologie de la reproduction. Supplément/Journal de gynécologie obstétrique et biologie de la reproduction
  12. Antitumor effect of membrane-type Tim-3 on hepatocellular carcinoma Hepa1-6 cells of ICR mice
    Ju Liu, Haiying Sun, Dan Shen, Mingmin Wang, Zirong Wen · 2017 · Oncology Letters
  13. Melanoma: An immunotherapy journey from bench to bedside
    Vishal Navani, Moira C. Graves, Hiren A. Mandaliya, Martin Hong, André van der Westhuizen, Jennifer H. Martin, Nikola A. Bowden · 2022 · Cancer treatment and research
  14. Current Trends in Immuno-Oncology
    Venkata Gangadhar Vanteddu, Sweta Bawari, Tulsi Dipakbhai Patel · 2022 · Cardiovascular & Hematological Agents in Medicinal Chemistry
  15. Perspectives on the Role of T Cell Negative Immune Checkpoint Receptors in Health and Disease
    Tsuyoshi Fujita, Danielle M. Clements, Thomas A. Premeaux, Lishomwa C. Ndhlovu · 2020 · Springer eBooks
  16. The stimulatory activity of plasma in patients with advanced non-small cell lung cancer requires TLR-stimulating nucleic acid immunoglobulin complexes and discriminates responsiveness to chemotherapy
    Zeng‐Guang Xu, Fengying Wu, Chunhong Wang, Xiyu Liu, Baoli Kang, Shan Shan, Xia Gu, Kailing Wang, Tao Ren · 2014 · Cancer Cell International
  17. Expression changes of Tim-3 as one of supplementary indicators for monitoring prognosis of liver pathological changes in chronic HBV infection
    Shanshan Wu, Xinfang Du, Guohua Lou, Shuihong Yu, Kecong Lai, Jinjin Qi, Shujun Ni, Zhi Jane Chen, Feng Chen · 2022 · BMC Infectious Diseases
  18. Unravelling the potential of TIM-3 gene polymorphism in allogeneic hematopoietic stem cell transplantation - a preliminary study
    Sylwia Biały, Jagoda Siemaszko, Małgorzata Sobczyk‐Kruszelnicka, Wojciech Fidyk, Iwona Solarska, Barbara Nasiłowska‐Adamska, Patrycja Skowrońska, Maria Bieniaszewska, Agnieszka Tomaszewska, Grzegorz Władysław Basak et al. · 2024 · Transplant Immunology
  19. Next generation immune checkpoints
    Natalia Muñoz Perez, Kirsten Moziak, Allison M. Martin · 2024 · Elsevier eBooks
  20. Novel Radiofluorinated Nanobody PET Tracer for Preclinical Studies of TIM3 Expression
    Dongye Zheng, Yong Huang, Chengze Li, Yanye Lu, Zhaoheng Xie, Ying Liang, Qiushi Ren, Xiangxi Meng · 2025 · Molecular Pharmaceutics
  21. T-cell apoptosis is more susceptible to overactivated neutrophils delivered-NETs-MPO/NE complex
    Cheng Lu, Lifei Shao, Heyue Li, Xi Gao, Yiwen Mei, Bingwei Sun · 2025 · International Immunopharmacology
  22. Reinvigorating the Cancer-Immunity Cycle by Intratumoral Administration of Conventional Dendritic Cells in Melanoma and Other Solid Tumors: A Narrative Review
    Manon Vounckx, Iris Dirven, Cleo Bertels, Julia Katharina Schwarze, Xenia Geeraerts, Sandra Tuyaerts, Anaïs Boisson, Karen E Willard-Gallo, Bart Neyns · 2026 · Vaccines
  23. TIM-3 in AML: a janus-faced orchestrator of immune exhaustion and leukemic self-renewal
    Ahmed M. Hjazi · 2026 · Cancer Cell International
  24. The plasmacytoid dendritic cell paradox in cancer: impaired type I interferon responses in a nucleic acid–rich tumor microenvironment
    Aliki Vasilakou, Séverine Loizon, Maxime Dubois, Paôline Laurent, Vanja Sisirak, Dorothée Duluc · 2026 · Frontiers in Immunology
  25. Extracellular Vesicles as Master Regulators of Immune Modulation in Multiple Myeloma
    Marzia Pucci, Elisa Costanzo, Martina Marfia, Gregorio Seidita, Simona Fontana, Chiara Corrado, Riccardo Alessandro · 2026 · International Journal of Molecular Sciences
  26. TIM3 alleviates microglia-mediated neuroinflammation in neuropathic pain by negatively regulating glycolysis-driven NLRP3 inflammasome activation
    J R Jiang, Yeqi Li, Mengyu Zhang, Cui Yin, Zhi Qi, Jie Xu, Chen Lu · 2026 · Acta Biochimica et Biophysica Sinica
  27. Progress in molecular markers associated with radiotherapy efficacy in glioma
    Xiang Gao, Yijing Ren, Lishan Gao, Hao Yu, Ping Zhou · 2026 · Frontiers in Oncology
  28. Highlights and summary of the 28th annual meeting of the Society for Immunotherapy of Cancer
    Paolo A. Ascierto, David H. Munn, Anna Karolina Palucka, Paul M. Sondel · 2014 · Journal for ImmunoTherapy of Cancer
  29. Role of Innate Immunity in Cancers and Antitumor Response
    Masahisa Jinushi, Muhammad Baghdadi · 2014 · Springer eBooks
  30. Nuclear DAMPs in Hepatic Injury and Inflammation
    Rui Kang, Daolin Tang · 2017 · Springer eBooks
  31. The major clinical components of cancer immunotherapy (modulating cell-mediated immune mechanisms)
    Challice Lee Bonifant, William Reece Burns · 2023 · Elsevier eBooks
  32. A New Method for Constructing Macrophage-Associated Predictors of Treatment Efficacy Based on Single-Cell Sequencing Analysis
    Jianxiu Lin, Yang Ran, Tengfei Wu, Zishan Wang, Jinjin Zhao, Yun Tian · 2023 · Journal of Immunotherapy
  33. Tumor-necrosis factor α-rich environment alters type-I interferon response to viral stimuli in patients with juvenile idiopathic arthritis by altering myeloid dendritic cell phenotype
    Irena Zentsová, Adam Klocperk, Markéta Bloomfield, Helena Kubešová, Hana Malcová, Dita Cebecauerová, Rudolf Horváth, Anna Šedivá, Zuzana Paračková · 2024 · Clinical Immunology
  34. Can tissue-specific PD-1/PD-L1 targeting combined with other immune checkpoint blockades enhance immune clearance?
    Sadia Ahmad, Amna Rehman, Ali Afzal, Muhammad Babar Khawar · 2024 · Medical Hypotheses
  35. Electroporation-mediated novel albumin-fused Flt3L DNA delivery promotes cDC1-associated anticancer immunity
    Ming‐Hung Hu, Darrell Fan, Hsin-Fang Tu, Ya-Chea Tsai, Liangmei He, Zhicheng Zhou, Michelle Cheng, Deyin Xing, Suyang Wang, Alexis Wu et al. · 2024 · Gene Therapy
  36. Enhancing the Efficacy of Checkpoint Blockade Through Combination Therapies
    Vikram R. Juneja, Martin W. LaFleur, Robert T. Manguso, Arlene H. Sharpe · 2016 · Springer eBooks
  37. High-Mobility Group Box 1 and Autophagy
    Daolin Tang, Rui Kang · 2016 · InTech eBooks
  38. Cell Death: Many Causes and Many Effects
    Dennis V. Cokkinos · 2019 · Springer eBooks
  39. Cancer Immunology
    Diane Tseng, Liora Michal Schultz, Drew M. Pardoll, Crystal Lee Mackall · 2020 · Elsevier eBooks
  40. Regulation of mast cell function by TIM-1 and TIM-3 signaling
    Binh L. Phong · 2016 · D-Scholarship@Pitt (University of Pittsburgh)
  41. An Overview of Acute Myeloid Leukemia and Cancer Immunology: (i) Concepts and Therapeutic Strategies and (ii) RepSox as a Candidate Cell-Engineering Tool
    Audrey Nadine Jajosky · 2014 · The Research Repository @ WVU (West Virginia University)
  42. Editorial: Countering immune regulation: sTim-ulating SLE disease pathogenesis
    Kiera Clayton, Mario Ostrowski · 2017 · Journal of Leukocyte Biology
  43. Cancer Immunology
    Mahsa Keshavarz‐Fathi, Mahdis Keshavarz-Fathi, Nima Rezaei · 2021 · Elsevier eBooks
  44. Tim-3
    Kiera Clayton, Mario Ostrowski · 2014 · Springer eBooks
  45. High Mobility Group Box B1
    Xuanbin Wang · 2016 · Springer eBooks
  46. Inflammatory Macrophages Lysate-based Macroporous Hydrogel for Effective Immunomodulation to Inhibit Tumor Progression, Recurrence and Metastasis
    Wanyu Li, Dan Wang, Tianshou Cao, Yanan Chen, Jilong Wang, Chihao Lin, Huiling Yang, Jiantao Lin, Junjie Deng · 2023 · Research Square
  47. Tim-3 Promotes Early Differentiation of Tbet + Effector T Cells During Acute Viral Infection
    Priyanka Manandhar, Emily Landy, Kanako Mori, Larry Kane · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  48. Regulation of T cell responses by the surface receptor Tim-3
    Jacob V. Gorman · 2014
  49. HMGB1 : regulation of inflammatory functions and therapeutic blockade
    Peter Lundbäck · 2015 · Figshare
  50. Tim-3 Regulation of Cancer Immunity
    Kaori Sakuishi, Ana Carrizosa Anderson · 2014 · Springer eBooks
  51. Mechanisms of Tim-3 Signal Transduction in the Modulation of Downstream TCR Signaling
    Judong Lee · 2013 · D-Scholarship@Pitt (University of Pittsburgh)
  52. Tumour antigen cross-presentation from irradiated tumour cells and the role of tlr4 polymorphism
    Josephine Salimu · 2014 · ORCA Online Research @Cardiff (Cardiff University)
  53. Reversing T Cell Dysfunction for Tumor Immunotherapy
    Larry Kane, Greg M. Delgoffe · 2016 · Springer eBooks
  54. Molecular Mechanisms of Tumor Dendritic Cell Dysfunction in Cancer
    Michael Tang · 2016 · TSpace (University of Toronto)
  55. Following the white rabbit : release and regulation of HMGB1 in inflammation
    Agnieszka Sowińska · 2019 · Figshare
  56. Immunology of Melanoma
    Paul F. Robbins, Yong‐Chen Lu · 2019 · Springer eBooks
  57. Dok-3 deficient mice display different immune clustering and Tim-3 expression
    Wenjiang Yan, Yijia Tian, Peng Sun, Jingjing Yang, Na Li, Yuanyuan Sun, Shuangxi Wang, Cheng Zhang · 2019 · European journal of medical research
  58. Tim-3/Galectin-9 Pathway Involves in the Homeostasis of CCl4 Induced Hepatitis
    Li‐Zhen Zhao, Mengli Cui, Dan Xu, Qi Han, Bei Zhang · 2019 · International Journal of Sciences
  59. Can the assessment of lymphocyte exhaustion serve as a prognostic predictor after lung cancer surgery?
    Kenji Morimoto, Yoshie Morimoto, Junji Uchino · 2020 · Translational Lung Cancer Research
  60. Cancer Immunotherapy
    Mohammad Raghibul Hasan, Bader Saud Alotaibi, Sultan F. Alnomasy, Khalid Umar Fakhri · 2020 · Advances in medical diagnosis, treatment, and care (AMDTC) book series
  61. usEPs as a Possible Immunotherapy
    Stephen J. Beebe · 2021 · Series in bioengineering
  62. 伊達政宗の小田原参陣と浅野長吉 : 当館寄託｢杉浦家文書｣の史料紹介を兼ねて
    貴浩 佐藤 · 2013 · Institutional Repositories DataBase (IRDB)
  63. Role of Innate Immunity in Cancers and Antitumor Response
    Masahisa Jinushi, Muhammad Baghdadi · 2020 · Springer eBooks
  64. Immunology of Melanoma
    Paul F. Robbins, Yong‐Chen Lu · 2020 · Springer eBooks
  65. Tim-3
    Kiera Clayton, Mario Ostrowski · 2018 · Springer eBooks
  66. Publications from Juntendo University Graduate School of Medicine, 2012
    2014 · Juntendō Igaku/Juntendo igaku
  67. High Mobility Group Box B1
    Xuanbin Wang · 2017 · Springer eBooks
  68. Regulation of the Intrahepatic CD8+ T Lymphocyte
    Joseph S. Dolina · 2013
  69. Publications from Juntendo University Graduate School of Medicine, 2012 [5/6]
    2015 · Juntendō Igaku/Juntendo igaku
  70. Faculty Opinions recommendation of Tim-3 promotes tumor-promoting M2 macrophage polarization by binding to STAT1 and suppressing the STAT1-miR-155 signaling axis.
    Larry Kane · 2018 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  71. Cancer Immunotherapy
    Padmanee Sharma, Swetha Anandhan, Bilal Ahmed Siddiqui, Sangeeta Goswami, Sumit Kumar Subudhi, Jianjun Gao, Karl S. Peggs, Sergio A. Quezada, James Patrick Allison · 2022 · Wiley eBooks
  72. New perspectives in the treatment of patients with intermediate-2 and high-risk myelodysplastic syndrome
    Elena Vladislavovna Morozova, Nikolai Tsvetkov, Maria V. Barabanshchikova, Ksenia Yurovskaya, Ivan Moiseev · 2022 · Oncohematology
  73. Checkpoint Blockade in Hematologic Malignancies
    Andriani Charalambous, Mark‐Alexander Schwarzbich · 2022 · Springer eBooks
  74. Data from High Mobility Group Protein B1 Decreases Surface Localization of PD-1 to Augment T-cell Activation
    Qun Gao, Shumin Wang, Feng Li, Jingyao Lian, Shaoyan Cheng, Dongli Yue, Zhen Zhang, Shasha Liu, Feifei Ren, Daiqun Zhang et al. · 2023
  75. Urinary and serum levels of high mobility group box 1
    Toshihiko Nakamura, Atsushi Yoshida, Daisuke Hatanaka, Michiko Kusakari, Hidehiro Takahashi, Shinji Katsuragi, Shingo Yamada, Takashi Kamohara · 2023 · Practical Laboratory Medicine
  76. [Tumor cell lysate with low content of HMGB1 enhances immune response of dendritic cells against lung cancer in mice].
    Z Pan, Shuang Li, Yue Wang, H Liu, Lin Gui, B Dong · 2023 · PubMed Central
  77. In the Pipeline: Emerging Therapy for MDS and MDS/MPN
    Harinder Gill, Emily Lee, Pinky Mo · 2023 · Springer eBooks
  78. TIM-3 blockade as a therapeutic approach for diffuse intrinsic pontine glioma
    Ausejo-Mauleón, I. (Iker) · 2023 · Deposito Adademico Digital Universidad De Navarra (University of Navarra)
  79. Other Immune Checkpoint Targets of Interest
    Clifford Michael Csizmar, Stephen Maxted Ansell · 2024 · Wiley eBooks
  80. WITHDRAWN: Next generation immune checkpoints
    Natalia Muñoz Perez, Kirsten Moziak, Allison M. Martin · 2024 · Elsevier eBooks
  81. Immune Checkpoint Inhibitors: Novel Therapies and Targets
    Elen Baloyan, Amalya Sargsyan, Karen Bedirian, Ruzanna Papyan, Gevorg Tamamyan, Samvel Bardakhchyan · 2024 · Interdisciplinary cancer research
  82. Plasma High-Mobility Group Box-1 and Galectin-9 in Patients with Trauma and Their Prognostic Potentials
    Toshiro Niki, Haorile Chagan Yasutan, Daisuke Furushima, Toshio Hattori, Yugo Ashino, Satoshi Yamanouchi, Shigeki Kushimoto · 2024 · The Tohoku Journal of Experimental Medicine
  83. Dissecting the causal role of immunophenotypes in brain meningioma risk: A Mendelian randomization study
    Xiaoyang Zhu, Yan Wang, Zhiyuan Liu, Xin Zhang, Shuaiqi Zhang, Bo Pang, Shu Zhu · 2025 · Medicine
  84. Checkpoint Blockade in Hematologic Malignancies
    Andriani Charalambous, Mark‐Alexander Schwarzbich · 2025 · Springer eBooks
  85. Emerging Insights into TIM-3: A Potential Immune Checkpoint for Lung Cancer Immunotherapeutic Strategies
    Omer Qutaiba B. Allela, Abdulkareem Shareef, Ashok Kumar Bishoyi, Rami Joseph Oweis, Suhas Ballal, Abhayveer Singh, Aashna Sinha, Subhashree Ray, Hayder Naji Sameer, Ahmed Yaseen et al. · 2025 · Immunological Investigations
  86. TIM-4 Regulates Allergic Airway Inflammation and Mast Cell Activation by Binding to CD300b
    Yuki Tanabe, Fumitaka Kamachi, Jun Ito, Norihiro Harada, Sonoko Harada, Fumihiko Makino, Yoshiyuki Abe, Nobuhiro Nakano, Kumi Izawa, François Niyonsaba et al. · 2025 · Journal of Asthma and Allergy
  87. Additional file 10 of Autophagy-based unconventional secretion of HMGB1 in glioblastoma promotes chemosensitivity to temozolomide through macrophage M1-like polarization
    Li, Zhuang, Fu, Wen-Juan, Chen, Xiao-Qing, Wang, Shuai, Deng, Ru-Song, Tang, Xiao-Peng, Yang, Kai-Di, Qin Niu, Zhou, Hong, Li, Qing-Rui et al. · 2022 · Figshare
  88. Additional file 11 of Autophagy-based unconventional secretion of HMGB1 in glioblastoma promotes chemosensitivity to temozolomide through macrophage M1-like polarization
    Li, Zhuang, Fu, Wen-Juan, Chen, Xiao-Qing, Wang, Shuai, Deng, Ru-Song, Tang, Xiao-Peng, Yang, Kai-Di, Qin Niu, Zhou, Hong, Li, Qing-Rui et al. · 2022 · Figshare
  89. Additional file 9 of Autophagy-based unconventional secretion of HMGB1 in glioblastoma promotes chemosensitivity to temozolomide through macrophage M1-like polarization
    Li, Zhuang, Fu, Wen-Juan, Chen, Xiao-Qing, Wang, Shuai, Deng, Ru-Song, Tang, Xiao-Peng, Yang, Kai-Di, Qin Niu, Zhou, Hong, Li, Qing-Rui et al. · 2022 · Figshare
  90. Additional file 7 of Autophagy-based unconventional secretion of HMGB1 in glioblastoma promotes chemosensitivity to temozolomide through macrophage M1-like polarization
    Li, Zhuang, Fu, Wen-Juan, Chen, Xiao-Qing, Wang, Shuai, Deng, Ru-Song, Tang, Xiao-Peng, Yang, Kai-Di, Niu, Qin, Zhou, Hong, Li, Qing-Rui et al. · 2022 · Figshare
  91. Additional file 4 of Autophagy-based unconventional secretion of HMGB1 in glioblastoma promotes chemosensitivity to temozolomide through macrophage M1-like polarization
    Li, Zhuang, Fu, Wen-Juan, Chen, Xiao-Qing, Wang, Shuai, Deng, Ru-Song, Tang, Xiao-Peng, Yang, Kai-Di, Qin Niu, Zhou, Hong, Li, Qing-Rui et al. · 2022 · Figshare
  92. Additional file 1 of Autophagy-based unconventional secretion of HMGB1 in glioblastoma promotes chemosensitivity to temozolomide through macrophage M1-like polarization
    Li, Zhuang, Fu, Wen-Juan, Chen, Xiao-Qing, Wang, Shuai, Deng, Ru-Song, Tang, Xiao-Peng, Yang, Kai-Di, Qin Niu, Zhou, Hong, Li, Qing-Rui et al. · 2022 · Figshare
  93. Additional file 1 of Characterization of a lipid droplet and endoplasmic reticulum stress related gene risk signature to evaluate the clinical and biological value in hepatocellular carcinoma
    Guo, Ziwei, Liang, Jun · 2023 · Figshare
  94. Additional file 3 of Autophagy-based unconventional secretion of HMGB1 in glioblastoma promotes chemosensitivity to temozolomide through macrophage M1-like polarization
    Li, Zhuang, Fu, Wen-Juan, Chen, Xiao-Qing, Wang, Shuai, Deng, Ru-Song, Tang, Xiao-Peng, Yang, Kai-Di, Niu, Qin, Zhou, Hong, Li, Qing-Rui et al. · 2022 · Figshare
  95. Additional file 12 of Autophagy-based unconventional secretion of HMGB1 in glioblastoma promotes chemosensitivity to temozolomide through macrophage M1-like polarization
    Li, Zhuang, Fu, Wen-Juan, Chen, Xiao-Qing, Wang, Shuai, Deng, Ru-Song, Tang, Xiao-Peng, Yang, Kai-Di, Qin Niu, Zhou, Hong, Li, Qing-Rui et al. · 2022 · Figshare
  96. Additional file 5 of Autophagy-based unconventional secretion of HMGB1 in glioblastoma promotes chemosensitivity to temozolomide through macrophage M1-like polarization
    Li, Zhuang, Fu, Wen-Juan, Chen, Xiao-Qing, Wang, Shuai, Deng, Ru-Song, Tang, Xiao-Peng, Yang, Kai-Di, Qin Niu, Zhou, Hong, Li, Qing-Rui et al. · 2022 · Figshare
  97. Additional file 8 of Autophagy-based unconventional secretion of HMGB1 in glioblastoma promotes chemosensitivity to temozolomide through macrophage M1-like polarization
    Li, Zhuang, Fu, Wen-Juan, Chen, Xiao-Qing, Wang, Shuai, Deng, Ru-Song, Tang, Xiao-Peng, Yang, Kai-Di, Niu, Qin, Zhou, Hong, Li, Qing-Rui et al. · 2022 · Figshare
  98. Additional file 2 of Autophagy-based unconventional secretion of HMGB1 in glioblastoma promotes chemosensitivity to temozolomide through macrophage M1-like polarization
    Li, Zhuang, Fu, Wen-Juan, Chen, Xiao-Qing, Wang, Shuai, Deng, Ru-Song, Tang, Xiao-Peng, Yang, Kai-Di, Niu, Qin, Zhou, Hong, Li, Qing-Rui et al. · 2022 · Figshare
  99. Additional file 6 of Autophagy-based unconventional secretion of HMGB1 in glioblastoma promotes chemosensitivity to temozolomide through macrophage M1-like polarization
    Li, Zhuang, Fu, Wen-Juan, Chen, Xiao-Qing, Wang, Shuai, Deng, Ru-Song, Tang, Xiao-Peng, Yang, Kai-Di, Qin Niu, Zhou, Hong, Li, Qing-Rui et al. · 2022 · Figshare
  100. TIM-3 inhibition enhances breast tumor progression and metastasis: A paradoxical immune checkpoint response
    Barnali Dolui, Banani Majumdar, Arghya Bandyopadhyay, Kartiki Vasant Desai, ANUPAM BASU · 2025 · Journal of Biological Chemistry